Publication | Closed Access

Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance

Increased HexobarbitalHepatologyLiver PhysiologyPharmacologyTolbutamide ClearanceHepatotoxicityPharmacotherapyMetabolismLiver DiseaseLiverMedicineDrug-induced Liver InjuryDrug Discovery